|Current selected tag: hyperlipidemia. Clear.|
Your new post is loading...
From 2000 to 2010, the number of people in the U.S. civilian noninstitutionalized population under age 40 obtaining at least one outpatient prescription anti-diabetic or anti-hypertensive increased.From 2000 to 2010, the total number of outpatient prescriptions for persons under age 40 increased for anti-diabetics, anti-hypertensives, and statins—41%, 49%, & 179%, respectively.Comparing 2000 with 2010, for persons under age 40 in the U.S. civilian noninstitutionalized population inflation adjusted total expenses increased for anti-diabetics (126%) and for statins (97%).From 2000 to 2010, for persons under age 40, the inflation adjusted average cost per drug purchase of a prescription anti-diabetic increased 61% from $77 to $124.From 2000 to 2010, for persons under age 40, the inflation adjusted average cost per drug purchase of a prescription anti-hypertensive and statin decreased.
Seth Bilazarian, MD's insight:
Despite the rise in obesity and incident diabetes and other associated risk factors such as high blood pressure and high cholesterol in children and young adults the treatment rates have increased very little over 10 years. Despite the known long term hazards there is a lack of data on treatment in patients less than 40 years old and therefore real hesitancy to treat by physicians.